Google reported the first confirmed AI-assisted zero-day exploit, raising new concerns about logic flaws, supply chain risk, and containment.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence.

Richard Socher's new $650 million startup wants to build an AI that can research and improve itself indefinitely — and he ...

Overview:  AI coding tools help developers write code faster, fix bugs more easily, and spend less time on repetitive work. Many tools also help with testi ...

A research team at Mohamed bin Zayed University of Artificial Intelligence published a finding in April 2026 that has gained traction in engineering circles for reasons that go beyond its headline ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

First AI zero-day: Google uncovered the first known zero-day exploit developed using AI, capable of bypassing two-factor authentication on a widely used administration tool. Attack foiled: The flaw ...